These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8992638)

  • 1. [Acute tolerance in hyperfractionated accelerated whole-body irradiation].
    Latz D; Schraube P; Wannenmacher M
    Strahlenther Onkol; 1996 Dec; 172(12):685-9. PubMed ID: 8992638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
    Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
    Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B
    Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ondansetron in the prophylaxis of acute emesis induced by supra-high single dose total body irradiation (TBI)].
    Huang X; Guo N; Fan Y
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):64-6. PubMed ID: 7656793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced emesis: effects of ondansetron.
    Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron for efficient emesis control during total body irradiation.
    Schwella N; König V; Schwerdtfeger R; Schmidt-Wolf I; Schmid H; Riess H; Siegert W
    Bone Marrow Transplant; 1994 Feb; 13(2):169-71. PubMed ID: 8205086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
    Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
    Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of granisetron in the prevention of digestive disorders in total body irradiation].
    Feuvret L; Jammet P; Campana F; Cosset JM; Fourquet A
    Bull Cancer Radiother; 1994; 81(1):41-4. PubMed ID: 7893522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT3 receptor antagonists ameliorate emesis in the ferret evoked by neutron or proton radiation.
    King GL; Rabin BM; Weatherspoon JK
    Aviat Space Environ Med; 1999 May; 70(5):485-92. PubMed ID: 10332945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of ondansetron in the management of radiotherapy-induced emesis.
    Roberts JT; Priestman TJ
    Oncology; 1993; 50(3):173-9. PubMed ID: 8459988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of granisetron per os in radiotherapy-induced emesis].
    Krengli M; Lazzari R; Manara M
    Minerva Med; 1996 Dec; 87(12):605-8. PubMed ID: 9064597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective emetic control during conditioning of children for bone marrow transplantation using ondansetron, a 5-HT3 antagonist.
    Hewitt M; Cornish J; Pamphilon D; Oakhill A
    Bone Marrow Transplant; 1991 Jun; 7(6):431-3. PubMed ID: 1831395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms].
    Saur P; Mühr C; Kazmaier S; Neumann P; Buhre W
    Anaesthesiol Reanim; 1996; 21(5):131-5. PubMed ID: 9044556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
    Tanimura S; Banba J; Tomoyasu H; Masaki M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
    Hirabayashi N; Goto S; Morishima Y; Sao H; Matsuyama T; Kodera Y; Yamada H; Horibe K; Yano K; Kojima H; Ogura M; Tanimoto M; Morishita Y; Yazaki M; Utsumi M; Nagata K; Kato Y; Naoe T; Saito H
    Rinsho Ketsueki; 1998 Jan; 39(1):21-6. PubMed ID: 9492549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.